Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DR26FMDW9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,602
Award facts
- Contract value 100% obligated
- $18,601.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $18,601.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The award, issued on November 14, 2025, represents a firm fixed-price delivery order with an ultimate completion date of December 8, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499,999,999 contract awarded on November 13, 2025, that positions the company as a critical regional pharmaceutical supplier for Department of Defense healthcare operations.
The PPV-G GEN V program represents a component of the broader $30.3 billion Defense Logistics Agency pharmaceutical acquisition strategy designed to supply a comprehensive range of branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders for diverse pharmaceutical products, including oncology treatments, immunosuppressants, vaccines, and specialty pharmaceuticals, demonstrates its capability to fulfill the specialized medical supply requirements of the federal military medical system. The company maintains no identified subcontractor relationships on this award, operating as the sole performer under the contract structure.
Quick answers
Who was awarded contract SPE2DR26FMDW9?
SPE2DR26FMDW9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FMDW9 worth?
The government has obligated $18,602 on SPE2DR26FMDW9.
Is contract SPE2DR26FMDW9 an order under another contract?
Yes. SPE2DR26FMDW9 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMDW9 competed?
The extent of competition for SPE2DR26FMDW9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award